INTRODUCTION
Transforming growth factor b (TGFb) family members are secreted homodimeric proteins that exert a wide range of biological effects on a large variety of cell types, including regulation of proliferation, differentiation, migration and apoptosis. Signaling by TGFb cytokines occurs via ligand-induced heteromeric complex formation of distinct type I and type II serine/threonine kinase receptors, causing the type I receptor to become phosphorylated by the constitutively active type II receptor. The activated TGFb type I receptor kinase propagates the signal within the cell through phosphorylation of the receptor-regulated (R-)Smad proteins Smad2 and Smad3 at their extreme carboxyl-terminal serine residues.
1,2 The activated R-Smads then form heteromeric complexes with the common-partner (Co-)Smad, Smad4, and accumulate in the nucleus, where they can bind DNA and regulate gene expression. The Smads control gene expression in a cell type-specific manner by interacting with other proteins, such as AP-1, AP-2 and Ets transcription factors and specific co-activators and co-repressors. [3] [4] [5] [6] [7] These interactions can alter the intensity, duration and specificity of the TGFb-signaling response.
Aberrant regulation of TGFb signaling has been implicated in several pathological situations such as carcinogenesis, vascular disorders and fibrosis. 6, 8 TGFb has a biphasic role in tumor progression. In the early stages of tumor development, TGFb inhibits cell growth and thus acts as a tumor suppressor. Escape from TGFb/Smad-induced growth inhibition and apoptosis is commonly observed in tumors. In late-stage cancer, TGFb has been shown to function as a tumor promoter, by stimulating dedifferentiation of epithelial cells to malignant invasive and metastatic fibroblastic cells. 6, 9 This epithelial-mesenchymal transition (EMT) is a complex process. It involves disruption of polarization of epithelial cells and gain of spindle-shaped morphology with formation of actin stress fibers, reduced cellcell junctions through delocalization and downregulation of E-cadherin, and increased cellular motility. Transcriptional repressors of E-cadherin, such as SIP1, Snail and Slug, are induced by TGFb. [9] [10] [11] Induction of EMT by TGFb can be observed in many different epithelial cell types and is promoted by activated Ras, activated Raf or by serum treatment. 12 It can be mediated both by perturbed Smad-dependent pathways and non-Smad signaling pathways, including MAP kinase pathways. 13, 14 Knockdown of Smad3 and Smad4, but not of Smad2, inhibits TGFb-induced EMT of NMuMG cells. 15, 16 The dimeric Jun/Fos and Jun/ATF AP-1 transcription factor complexes are composed of c-Jun, JunB, JunD, c-Fos, FosB, Fra1, Fra2 and certain ATF members, such as ATF2. These proteins control cell proliferation and differentiation by regulating gene expression in response to a wide range of stimuli, and they can be induced and/or activated through multiple signaling pathways, for example, MAP kinase pathways. [17] [18] [19] [20] Certain AP-1 components have been implicated in carcinogenesis and tumor cell invasion. [20] [21] [22] [23] In the case of TGFb family signaling, both Smaddependent and Smad-independent pathways can contribute to AP-1 activation. 4, 14 Previously, we established a 3D model of collagen-embedded spheroids of non-malignant, premalignant and metastatic MCF10A human breast cancer cells. We showed that in this system TGFb-receptor I kinase and Smad4 and Smad3 are essential factors for TGFb-induced invasion, by activating among others the secreted proteases MMP-2 and MMP-9. 24 In the present study, we have used this breast cancer invasion model to analyze the role of specific transcription factor AP-1 components in TGFb/ Smad-induced invasion.
RESULTS
TGFb signaling induces increased levels of various AP-1 components in MCF10A MII cells We previously showed that Smad4 and Smad3 have critical roles in TGFb-induced invasion of both premalignant (MII) and malignant (MIV) MCF10A breast epithelial cells. 24 As Smads can regulate gene expression in cooperation with AP-1 transcription factors, and various AP-1 components have been implicated in tumor cell invasion, we first examined whether the expression of AP-1 components is regulated by TGFb in MCF10A MII cells. As MII cells are Ras-transformed cells that can secrete various growth factors and cytokines themselves, including TGFb and/or TGFb-related cytokines, 24 we examined non-stimulated and TGFbstimulated cells both in the absence and presence of the TGFbRI kinase inhibitor SB-505124. Activation (phosphorylation) of Smad2 and Smad3 was analyzed for comparison.
We used TGFb3 in this study because little is known about the response of breast cancer cells to TGFb3, in contrast to TGFb1. All three TGFb isoforms are expressed during breast cancer progression, but some contradictory results have been obtained with respect to the correlation between expression levels and prognosis (reviewed in Laverty et al. 25 ). Importantly, both TGFb1 and TGFb3 can bind directly to the type II receptor (TGFbRII), whereas TGF-b2 requires the presence of the co-receptor b-glycan. Moreover, we found the binding pattern of TGFb3 in M2 cells to closely match the pattern reported for TGFb1, binding TGFbRII, ALK5/TGFbRI and b-glycan. [24] [25] [26] However, in certain assays TGFb3 appears to be a slightly more potent stimulator than TGFb1. 25 As shown in Figure 1 and Supplementary Figure 1 , we found TGFb to strongly increase the protein levels of the AP-1 components c-Jun, JunB, c-Fos and FosB. The TGFbRI kinase inhibitor SB-505124 inhibited the induction of c-Jun, JunB, c-Fos and FosB by TGFb only at later time points (6 and 16 h; Figure 1 ). However, phosphorylation of Smad2 and Smad3 by TGFb was already efficiently inhibited by SB-505124 after 1 h. Therefore, the Jun and Fos induction detected at the 1-h time point is most likely due to non-TGFbRI kinase-dependent TGFb signaling.
14 Fra1, Fra2 and ATF2 were easily detected in non-stimulated MII cells, but only minor effects on expression levels were recorded upon addition of TGFb or TGFbRI kinase inhibitor. Finally, the increase in c-Fos and Fra2 in the non-treated cells detected after 16 h, which was weakly inhibited by SB-505124, was probably due to autocrine factors, some of which might be TGFb related and/or dependent.
Differential effects of AP-1 components on MCF10A MII spheroid invasion We next analyzed the role of AP-1 in TGFb-induced collagen invasion of MII spheroids. For this purpose, we first specifically depleted AP-1 components with validated Dharmacon (VWR International AB, Stockholm, Sweden) smart-pool siRNAs (Figure 2a) . Knockdown of individual AP-1 components had only minor effects on the other members, with the exception of c-Fos and Fra1 that were significantly decreased by knockdown of c-Jun or JunB. These effects of AP-1 proteins on other family members are most likely due to the fact that various AP-1 components are (auto-)regulated via AP-1-binding sites in their promoters, and the fact that Fos family members can be stabilized by dimerization to Jun family members. 18, 20, 27 The reduced c-Jun levels upon Smad4 knockdown in Figure 2a indicate that the late TGFb induction of c-jun is Smad dependent, which is in line with previous studies. 4, 14 The effect of AP-1 knockdown on invasion was subsequently compared with the effect of the TGFbRI-kinase inhibitor SB-505124 and Smad4 siRNA, as our previous studies had shown that TGFbRI-kinase inhibition nearly completely blocks TGFb-induced collagen invasion of MII spheroids, whereas knockdown of Smad4 only has a partial effect. 24 Importantly, siRNA-mediated knockdown of none of the AP-1 components affected the formation of spheroids (Figure 2b ). However, knockdown of JunB strongly inhibited TGFb-induced collagen invasion, whereas knockdown of c-Jun, c-Fos and Fra1 inhibited invasion to a slightly lower extent (Figures 2c and d) . Knockdown of ATF2, FosB or Fra2 not or hardly inhibited TGFb-induced collagen invasion (Figures 2c and d) . These results therefore suggest that the induction of c-Jun, JunB and c-Fos by TGFb is an essential step during TGFb-induced invasion of MII cells, and that only a specific subset of AP-1 components is essential.
Identification of Smad and AP-1-dependent mesenchymal and invasion-associated genes We next tried to obtain clues on the mechanism by which AP-1 mediates TGFb-induced invasion in MII cells. For this, we examined the effect of c-Jun, JunB, c-Fos or Fra1 knockdown on the expression of a panel of invasion-and EMT-associated TGFb target genes. As shown in Figure 3a , c-Jun, JunB and Fra1, but not c-Fos, were found to be critical for the TGFb-induced expression of mmp-1, mmp-9 and mmp-10. However, TGFb induction of mmp-2 and integrin a v was not at all or only minimally decreased by knockdown of these AP-1 components (Figures 3a and b) . c-Jun and JunB were also found to contribute to TGFb induction of slug, uPAR and pai-1, and both c-Fos and Fra1 appeared to be involved in the induction of slug and pai-1 ( Figure 3b ). In contrast, the induction of snail was dependent on c-Fos, but not on Fra1 (Figure 3c ). All genes examined required Smad4 (Figures 3a-c) . These results thus indicate that Jun/c-Fos and Jun/Fra1 complexes control distinct subsets of Smad4-dependent EMT and invasion-associated genes. As TGFb strongly enhanced the synthesis of c-Jun and JunB (Figure 1 ), we subsequently examined the effect of Jun overexpression on the expression of mmp-1, -2 and -10. As shown in Figure 4a , transient transfection of c-Jun induced the expression of endogenous mmp-1 and -10 both with and without TGFb treatment for 4 h. However, transfection of JunB only had a weak stimulatory effect on TGFb-induced mmp-10, suggesting that enhanced levels of JunB by itself are not sufficient. The expression of mmp-2 was somewhat inhibited by overexpressed c-Jun and JunB (Figure 4a ), in line with the slight enhancement by the Jun knockdown in Figure 3a . As overexpressed Smad and Jun proteins were previously shown to be able to cooperatively activate Smad/ AP-1-dependent reporter plasmids in the absence of TGFbstimulation, 3, 4 we next overexpressed JunB together with Smad3 and 4. Like JunB, overexpressed Smad3 and 4 could not activate the endogenous mmp-1 and mmp-10 genes by themselves, although the TGFb-inducible reporter plasmid CAGA-luciferase was efficiently induced under these conditions (data not shown). However, the combination of JunB, Smad3 and Smad4 induced these genes to the same extent as overexpression of c-Jun (see the fold activation in Figures 4a and b) . These data further confirm that both c-Jun and JunB contribute to the TGFb-and Smadinduced activation of specific mmp genes in MII cells.
In situ detection of Smad-AP-1 interaction by proximity ligation Some Smad members and AP-1 components, for instance Smad3 and c-Jun, have been found to associate in vitro and/or upon overexpression. 3, 4 To examine whether we could detect endogenous complexes between Smad proteins and AP-1 components in MII cells in situ, we performed proximity ligation assays (PLA). 28, 29 TGFb treatment induced formation of nuclear complexes of Smad3 and Smad4, while nuclear complexes of c-Jun and Smad3, andto a lesser extent-JunB and Smad3, were already present in non-stimulated cells, and only weakly increased upon TGFb treatment (Figures 5a and c) . We could not consistently detect complex formation between Smad4 and the Jun proteins under these conditions, and only detected very low levels of Smad2 binding to Smad4 and the AP-1 components in these cells (data not shown). Interactions between c-Jun and Fra1 and between JunB and Fra1 were clearly detectable in many but not all non-stimulated cells, and only c-Jun/Fra1 complexes were clearly increased by TGFb (Figures 5b and c) . Some c-Jun/c-Fos complexes were also already present in non-stimulated cells, but their levels were considerably higher after TGFb stimulation. However, the strongest stimulatory effect of TGFb was observed on the interaction between Smad2/3 and Fra1 (Figures 5b and c) .
(Note that we cannot rule out the presence of Smad2 in these complexes because the antibody used can recognize both Smad2 and Smad3.) In contrast, much less complexes were detected that contained Smad2/3 and c-Fos (Figures 5b and c) . In the presence of the TGFbRI inhibitor SB-505124, TGFb was unable to increase most of these Smad and AP-1 complexes (Figure 5c ).
These results show that both c-Jun and JunB can interact with nuclear Smad3 in MII cells also in the absence of TGFb stimulation, whereas the interaction between Smad2/3 and Fra1 seems to be efficiently enhanced upon activation of TGFb signaling.
c-Jun, JunB and Fra1 enable TGFb-induced binding of Smad2/3 to the mmp-10 and pai-1 promoters TGFb-induced binding of Smad2/3 to the promoters of TGFbtarget genes represents a critical step in TGFb/Smad-induced gene activation. 5, 6 To further elucidate the mechanism by which c-Jun, JunB, c-Fos and Fra1 mediate TGFb-induced expression of invasion genes, we analyzed Smad2/3 promoter recruitment in MII cells in the absence and presence of these AP-1 components. As shown by the chromatin immunoprecipitations (ChIP) in Figure 6 , the binding of Smad2/3 to the promoters of mmp-10 and pai-1 was efficiently increased by TGFb treatment. As expected, knockdown of Smad4 strongly inhibited Smad2/3 binding. Importantly, knockdown of c-Jun, JunB and Fra1 also strongly reduced Smad2/3 binding to the mmp-10 promoter, but knockdown of c-Fos did not. Moreover, both JunB and Fra1 were critical for Smad2/3 recruitment to the pai-1 promoter. Together with the mRNA analysis and PLAs presented above, these results indicate that interactions involving Smad3, c-Jun, JunB and Fra1, but not c-Fos, are critical for the TGFb-induced binding of Smad3 to AP-1-dependent TGFb-induced invasion genes.
DISCUSSION
TGFb signaling has a dual role in cancer. In the early stages of tumor development, it can inhibit carcinogenesis through TGFb/ Smad-induced growth inhibition and apoptosis. However, during later stages of cancer progression, TGFb can promote tumor invasion and metastasis by inducing EMT and affecting the tumor stroma, thereby enhancing survival, motility and invasion of the tumor cell. To overcome the tumor-suppressive effect of the TGFb pathway, the core components-including Smad2 and Smad4-are frequently inactivated in cancer tissue, for instance in colorectal cancer. However, breast cancers mainly exhibit defects in downstream mediators of the cytostatic action of TGFb. They exhibit normal signaling from receptors to Smads and retain or gain other properties of TGFb responsiveness, indicating that TGFb/Smad signaling is critical for breast cancer progression. [30] [31] [32] [33] [34] [35] [36] Induction of EMT and invasion by TGFb is promoted by activated Ras, and can be mediated both via Smad-dependent pathways and non-Smad signaling such as by MAP kinase pathways.
9,12-14,37 As TGFb, Ras and MAP kinases can activate transcription factor AP-1, we have in this study investigated which role the individual components of transcription factor AP-1 complexes play in TGFb-induced breast cancer cell invasion. TGFb was found to induce increased protein levels of c-Jun, JunB, c-Fos and FosB with prolonged kinetics (at least up to 16 h) in MCF10A-MII cells, whereas Fra1, Fra2 and ATF2 were efficiently expressed, but not or only slightly affected by TGFb stimulation. The TGFbRI kinase inhibitor SB-505124 inhibited the induction of c-Jun, JunB, c-Fos and FosB only at the later time points, suggesting that the early activation is mediated by TGFbRI kinase-independent JNK/p38 activation.
14 By using a validated siRNA approach, we could show that c-Jun, JunB, c-Fos or Fra1 are required for efficient TGFb-induced invasion, whereas FosB and Fra2 did not contribute. It is important to note though that-in spite of their different transcriptional activities-c-Fos, FosB, Fra1 and Fra2 can all dimerize with the Jun proteins and share some critical functions in cell cycle control and mouse development. 17, 19, 38 Therefore, we cannot yet exclude that in the absence of c-Fos and/or Fra1 proteins, FosB and/or Fra2 may, to some extent, take over their functions in TGFb-induced invasion. Similarly, c-Fos may take over some functions of Fra1 upon Fra1 depletion and vice versa. Interestingly, none of the siRNAs used inhibited the invasion to the same extent as the TGFRI-kinase inhibitor SB-505124. This could point to further redundancy within the Smad, Jun and Fos families, or to involvement of additional TGFb-regulated and/or cooperating factors, such as Rho kinases and Ets transcription factors. 6, 7, 14 We found that both c-Fos and Fra1 contribute to TGFbmediated induction of the mesenchymal and EMT-associated genes pai-1 and slug, which supports the idea that these two Jun dimer-partners have (at least partially) overlapping functions in invasion. However, additional results showed that c-Fos and Fra1 also exhibit unique functions in the induction of EMT and invasion genes by TGFb: only c-Fos was found to be required for efficient induction of snail, whereas only Fra1 was essential for the induction of mmp-1 and mmp-9. The expression of mmp-10 was also strongly dependent on the presence of Fra1, while c-Fos had limited effects. Moreover, ChIPs showed that Fra1 but not c-Fos is critical for the TGFb-induced binding of Smad2/3 to the pai-1 and mmp-10 promoters, and with PLAs we could only efficiently detect TGFb-induced complexes between Smad2/3 and Fra1. These results indicate that Fra1 rather than c-Fos is required for the recruitment of Smads to the Smad/AP-1 sites of these invasion-associated genes, whereas c-Fos may mainly act on pai-1 via (Smad-independent) AP-1 sites. Interestingly, knockdown of c-Jun also did not affect Smad2/3 recruitment to pai-1 (Figure 6 ), suggesting that both c-Jun and c-Fos activate pai-1 in a Smad2/3-independent manner, in contrast to JunB and Fra1. In fact, c-Jun might also activate the mmp-1 and mmp-10 genes in part via a Smad-independent mechanism, as overexpression of c-Jun, but not of JunB, could activate these mmp genes in the absence of TGFb stimulation or Smad3/4 overexpression (Figure 4a ).
Previous studies in human cells and/or in mouse models showed that c-Fos and Fra1 can both have essential roles in EMT and tumor progression, thereby presumably participating in Jun/ Fos trancription complexes binding to AP-1 sites in genes critical for EMT, survival and/or migration/invasion. 19, [21] [22] [23] 39, 40 Whether some of these functions are mediated via interaction with Smad proteins is to our knowledge still unknown. However, it is important to mention here that TGFb itself is an AP-1 target gene, indicating that AP-1 components are likely to control the persistence of TGFb signaling at multiple levels.
In the absence of active TGFbRI, Smad proteins shuttle between the nucleus and cytoplasm, whereas AP-1 components are (predominantly) located in the nucleus. Our PLAs showed that 1 h TGFb treatment induces not only complexes between Smad3 and Smad4 in the nucleus but also complexes between Smad2/3 and Fra1, whereas complexes between Smad3, c-Jun and JunB could already be detected before TGFb stimulation. At later time points after stimulation, when the levels of c-Jun and JunB are strongly increased, we also saw a stronger increase in Smad3/Jun complexes (our unpublished observations). These complexes might therefore further enhance Smad-AP-1-dependent TGFb target genes and thus alter the intensity and duration, as well as the specificity of the Smad-signaling response. Moreover, in certain situations-such as in the case of mmp-2 ( Figure 4 )-they might inhibit Smad-dependent transcription via off-DNA interactions. 4, 41 In summary, our results show that specific AP-1 members determine TGFb signaling specificity in EMT and breast cancer cell invasion by functionally interacting with Smad factors. Our results further suggest that in particular formation of Smad2/3-Fra1 complexes may reflect activation of the Smad/AP-1-dependent TGFb-induced invasion program. Previously, we found that aggressive basal-like breast cancer cells can be discriminated from much less invasive luminal-like cells by PLA detection of c-Jun/Fra1, rather than of c-Jun/ATF2 and c-Jun/c-Fos. 29 JunB/Fra1 dimers were also found to be increased in the aggressive cells (our unpublished observations). It will therefore be interesting to compare Smad/AP-1 complex formation in basal-like breast cancer cells versus luminal-like cells, and in biopsies of breast cancer patients.
MATERIALS AND METHODS

Cell culture
MCF10A MII cells were obtained from Dr Fred Miller (Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA) and maintained at 37 1C and 5% CO 2 in DMEM/F12 (Gibco, Life Technologies Europe BV, Stockholm, Sweden) supplemented with 5% fetal bovine serum (Biowest, Biotech-IgG AB, Lund, Sweden), 20 ng/ml epidermal growth factor (Upstate, Millipore AB, Solna, Sweden), 100 ng/ml cholera toxin (Sigma, Sigma-Aldrich Sweden AB, Stockholm, Sweden), 0.5 mg/ml hydrocortisone (Sigma) and 10 mg/ml insulin (Sigma).
3D spheroid invasion assays
Semi-confluent cells were trypsinized, counted and re-suspended in medium containing 2.4 mg/ml methylcellulose (Sigma) at the concentration of 10 4 cells/ml. A 100-ml of suspension was added into each well of U-bottom 96-well plate allowing the formation of one spheroid per well. For siRNA-mediated knockdown, the trypsinized cells were incubated with specific smart-pool siRNAs obtained from Dharmacon according to the manufacturers procedure. All spheroids consisted of 10 3 cells. Two days after plating spheroids were harvested and embedded into collagen. Flatbottom 96-well plates were coated with neutralized bovine collagen-I (PureCol, Advanced BioMatrix, Nutacon BV, Leimuiden, The Netherlands) according to manufacturer's protocol. Single spheroids were embedded in a 1:1 mix of neutralized collagen and medium supplemented with 12 mg/ml of methylcellulose. TGFb3 (generous gift of Dr K Iwata, OSI Pharmaceuticals, Inc., New York, NY, USA) and/or SB-505124 (Sigma) were directly added to the embedding solution. Invasion was quantified by measuring the area occupied by cells at day 2 by using Adobe Photosphop CS3 software. Pictures were taken at day 0 and day 2 after embedding. RNA isolation, cDNA synthesis and quantitative real time-PCR Cells were treated as described for western analysis and total RNA was isolated by GeneJET RNA Purification Kit (Fermentas, Helsingborg, Sweden). cDNA was prepared by annealing 1 mg RNA with oligo dT as per manufacturer's instructions (RevertAid H Minus First Strand cDNA Synthesis Kit, Fermentas). The cDNA samples were diluted 10 times with water. A total of 2 ml of cDNA was used in 12 ml quantitative real time-PCR reactions with appropriate primers and Maxima SYBR Green qPCR MasterMix (Fermentas). All samples were analyzed in triplicate for each primer set. Gene expression levels were determined with the comparative DC t method and the non-stimulated condition was set to 1. Relative expression levels are presented as mean ± s.d. Statistical significance was determined by unpaired Student's two-tailed t-test. Po0.05 was considered as statistically significant. The complete primers list can be found in the Supplementary Table S1 .
Western blot analysis
Proximity ligation assay
Cells were seeded on tissue culture-treated chamber slides (REF 354108; BD Falcon, BD Biosciences, BD AB, Stockholm, Sweden). The following day, cells were starved 16 h in 0.2% FBS and stimulated with 5 ng/ml of TGFb3 for 1 h. Cells were fixed as described previously. 29 The slides Figure 6 . c-Jun, JunB and Fra1 determine Smad2/3 binding to the mmp-10 and pai-1 promoters. MCF10A MII cells were transfected with the indicated control (ns: non-specific) or specific siRNAs, serum-starved and stimulated for 16 h with TGFb3. ChIP was performed with an antibody against Smad2, 3 and normalized to control IgG. The fold enrichment for non-stimulated control transfected cells was set at 1.0 for each gene.
were then blocked in 5% donkey serum (Jackson Immunoscience, Jackson ImmunoResearch Europe Ltd, Suffolk, UK), 2 mg/ml salmon sperm (Sigma), 5 mg/ml bovine serum albumin (Sigma) and 2 mM cysteine (Sigma) in TBS- 
Chromatin immunoprecipitation
Cells were cultured in 10 cm plates to approximately 80-90% confluence, and one plate was used per immunoprecipitation. Cells were fixed with 1% formaldehyde for 10 min at room temperature with swirling. Glycine was added to a final concentration of 0.125 M, and the incubation was continued for an additional 5 min. Cells were washed twice with ice-cold phosphate-buffered saline, harvested by scraping, pelleted and resuspended in 1 ml of SDS lysis buffer (50 mM Tris-HCl (pH 8.0), 1% SDS, 10 mM EDTA, protease inhibitors; complete EDTA-free protease inhibitors (Roche Diagnostics, Rotkreuz, Switzerland)). Samples were sonicated three times for 30 s each time at intervals of 30 s with a Diagenode Bioruptor sonicator. Samples were centrifuged at 14 000 r.p.m. at 8 1C for 10 min. After removal of a control aliquot, supernatants were diluted 10-fold in ChIP dilution buffer (20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 2 mM EDTA, 1% Triton X-100). Samples were incubated at 4 1C overnight in 2-methacryloyloxyethyl phosphorylcholine polymer-treated 15 ml polypropylene tubes (Assist, Tokyo, Japan) with anti-mouse IgG-Dynabeads that had been preincubated with 5 mg of antibodies in phosphatebuffered saline-0.5% bovine serum albumin. The beads were then moved to 1.7 ml siliconized tubes (catalog no. 3207; Corning, Corning, NY, USA) and washed five times with ChIP wash buffer (50 mM HEPES-KOH (pH 7.0), 0.5 M LiCl, 1 mM EDTA, 0.7% deoxycholate, 1% Igepal CA630) and once with TE buffer (pH 8.0). Immunoprecipitated samples were eluted and reverse cross-linked by incubation overnight at 65 1C in elution buffer (50 mM Tris-HCl (pH 8.0), 10 mM EDTA, 1% SDS). Genomic DNA was then extracted with a PCR purification kit (Qiagen, Qiagen Nordic, Sollentuna, Sweden). The immunoprecipitated DNA was analyzed by qPCR assay using specific primers for the human pai-1 gene: forward, 
